| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LBW242 | CCLE | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.088 | 0.06 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.082 | 0.07 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.074 | 0.1 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.072 | 0.1 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.06 | 0.2 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.05 | 0.3 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.048 | 0.3 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.045 | 0.3 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.046 | 0.3 |